ORMP
Price
$2.38
Change
-$0.11 (-4.42%)
Updated
Dec 20, 04:59 PM (EDT)
66 days until earnings call
PULM
Price
$5.98
Change
+$0.07 (+1.18%)
Updated
Dec 20, 04:59 PM (EDT)
Ad is loading...

ORMP vs PULM

Header iconORMP vs PULM Comparison
Open Charts ORMP vs PULMBanner chart's image
Oramed Pharmaceuticals
Price$2.38
Change-$0.11 (-4.42%)
Volume$2.34K
CapitalizationN/A
Pulmatrix
Price$5.98
Change+$0.07 (+1.18%)
Volume$1.24K
CapitalizationN/A
ORMP vs PULM Comparison Chart
Loading...
ORMP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PULM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ORMP vs. PULM commentary
Dec 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ORMP is a Hold and PULM is a Hold.

COMPARISON
Comparison
Dec 23, 2024
Stock price -- (ORMP: $2.37 vs. PULM: $6.00)
Brand notoriety: ORMP and PULM are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ORMP: 66% vs. PULM: 9%
Market capitalization -- ORMP: $95.94M vs. PULM: $21.91M
ORMP [@Biotechnology] is valued at $95.94M. PULM’s [@Biotechnology] market capitalization is $21.91M. The market cap for tickers in the [@Biotechnology] industry ranges from $464.4B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ORMP’s FA Score shows that 0 FA rating(s) are green whilePULM’s FA Score has 1 green FA rating(s).

  • ORMP’s FA Score: 0 green, 5 red.
  • PULM’s FA Score: 1 green, 4 red.
According to our system of comparison, both ORMP and PULM are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ORMP’s TA Score shows that 3 TA indicator(s) are bullish while PULM’s TA Score has 5 bullish TA indicator(s).

  • ORMP’s TA Score: 3 bullish, 7 bearish.
  • PULM’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, PULM is a better buy in the short-term than ORMP.

Price Growth

ORMP (@Biotechnology) experienced а -4.05% price change this week, while PULM (@Biotechnology) price change was +4.35% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.20%. For the same industry, the average monthly price growth was -1.27%, and the average quarterly price growth was +2.17%.

Reported Earning Dates

ORMP is expected to report earnings on Feb 26, 2025.

PULM is expected to report earnings on Nov 08, 2024.

Industries' Descriptions

@Biotechnology (-2.20% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ORMP($95.9M) has a higher market cap than PULM($21.9M). PULM YTD gains are higher at: 222.581 vs. ORMP (2.597). ORMP has higher annual earnings (EBITDA): 9.44M vs. PULM (-6.78M). ORMP has more cash in the bank: 142M vs. PULM (10.8M). PULM has less debt than ORMP: PULM (0) vs ORMP (429K). PULM has higher revenues than ORMP: PULM (10M) vs ORMP (0).
ORMPPULMORMP / PULM
Capitalization95.9M21.9M438%
EBITDA9.44M-6.78M-139%
Gain YTD2.597222.5811%
P/E Ratio21.64N/A-
Revenue010M-
Total Cash142M10.8M1,315%
Total Debt429K0-
FUNDAMENTALS RATINGS
ORMP vs PULM: Fundamental Ratings
ORMP
PULM
OUTLOOK RATING
1..100
7250
VALUATION
overvalued / fair valued / undervalued
1..100
67
Overvalued
31
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
8498
PRICE GROWTH RATING
1..100
4934
P/E GROWTH RATING
1..100
48100
SEASONALITY SCORE
1..100
n/a95

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

PULM's Valuation (31) in the Biotechnology industry is somewhat better than the same rating for ORMP (67) in the Pharmaceuticals Other industry. This means that PULM’s stock grew somewhat faster than ORMP’s over the last 12 months.

PULM's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as ORMP (100) in the Pharmaceuticals Other industry. This means that PULM’s stock grew similarly to ORMP’s over the last 12 months.

ORMP's SMR Rating (84) in the Pharmaceuticals Other industry is in the same range as PULM (98) in the Biotechnology industry. This means that ORMP’s stock grew similarly to PULM’s over the last 12 months.

PULM's Price Growth Rating (34) in the Biotechnology industry is in the same range as ORMP (49) in the Pharmaceuticals Other industry. This means that PULM’s stock grew similarly to ORMP’s over the last 12 months.

ORMP's P/E Growth Rating (48) in the Pharmaceuticals Other industry is somewhat better than the same rating for PULM (100) in the Biotechnology industry. This means that ORMP’s stock grew somewhat faster than PULM’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ORMPPULM
RSI
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
73%
Bullish Trend 3 days ago
74%
Momentum
ODDS (%)
Bearish Trend 3 days ago
79%
Bullish Trend 3 days ago
71%
MACD
ODDS (%)
Bearish Trend 3 days ago
81%
Bearish Trend 3 days ago
86%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
81%
Bullish Trend 3 days ago
72%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
85%
Bullish Trend 3 days ago
75%
Advances
ODDS (%)
Bullish Trend 4 days ago
82%
Bullish Trend 6 days ago
70%
Declines
ODDS (%)
Bearish Trend 6 days ago
84%
Bearish Trend 10 days ago
86%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
83%
N/A
Aroon
ODDS (%)
Bearish Trend 3 days ago
84%
Bullish Trend 3 days ago
89%
View a ticker or compare two or three
Ad is loading...
ORMP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PULM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VIVK1.220.14
+12.96%
Vivakor
GYRE11.140.48
+4.50%
Gyre Therapeutics
FPH3.580.15
+4.37%
Five Point Holdings LLC
BHVN36.260.92
+2.60%
Biohaven Ltd
DRI187.594.15
+2.26%
Darden Restaurants

ORMP and

Correlation & Price change

A.I.dvisor indicates that over the last year, ORMP has been loosely correlated with BPMC. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if ORMP jumps, then BPMC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ORMP
1D Price
Change %
ORMP100%
-4.82%
BPMC - ORMP
44%
Loosely correlated
+1.36%
BTAI - ORMP
44%
Loosely correlated
+8.12%
INO - ORMP
44%
Loosely correlated
-0.27%
MBIO - ORMP
44%
Loosely correlated
+1.64%
VERV - ORMP
44%
Loosely correlated
+11.24%
More

PULM and

Correlation & Price change

A.I.dvisor indicates that over the last year, PULM has been loosely correlated with ORMP. These tickers have moved in lockstep 33% of the time. This A.I.-generated data suggests there is some statistical probability that if PULM jumps, then ORMP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PULM
1D Price
Change %
PULM100%
+1.52%
ORMP - PULM
33%
Loosely correlated
-4.82%
INM - PULM
30%
Poorly correlated
+6.25%
GERN - PULM
27%
Poorly correlated
-4.64%
TSHA - PULM
26%
Poorly correlated
N/A
PMVP - PULM
25%
Poorly correlated
N/A
More